Infectious plasmodium sporozoites grown in vitro
US9878026B2 · kind B2 · utility
5Cited by
9References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 11, 2016 |
| Grant date | Jan 30, 2018 |
| Priority date | — |
| Expiry date | Apr 11, 2036 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The application is directed to in-vitro-reared Plasmodium sporozoites of human host range wherein sporogony from gametocyte stage to sporozoite stage is external to mosquitoes, and methods of producing the same. Provided herein are in vitro-reared infectious Plasmodium sporozoites (SPZ) of human host range, particularly P. falciparum, P. vivax, P. ovale, P. malariae, and P. knowlesi, wherein sporogony from gametocyte stage to sporozoite stage is external to mosquitoes, and methods of producing the same.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.